Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.
WHO is investigating the potential of certain biosimilars in a prequalification pilot program.
Initially, The American College of Rheumatology was cautious about biosimilars, but times have changed.
The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.
Why does the full potential of biosimilars remain untapped? Four experts weigh in.
The latest business news and views in pharma.
Why is the pharma industry overly reluctant to accept new ideas?
FDA Commissioner Scott Gottlieb wants more biosimilars on the US market.
Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA
EMA relocation, a price-fixing scandal, and FDA warning letters… What's new for pharma in business?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.